|
1.
|
|
7 p, 884.3 KB |
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
/
Rejeski, Kai (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Burchert, Andreas (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Iacoboni, Gloria (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sesques, Pierre (Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France) ;
Fransecky, Lars (Universitätsklinikum Schleswig-Holstein (Alemanya)) ;
Bücklein, Veit (Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany) ;
Trenker, Corinna (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Hernani, Rafael (Hospital Clínic Universitari (València)) ;
Naumann, Ralph (Medical Department III-Hematology and Oncology, St. Marien-Krankenhaus Siegen, Siegen, Germany) ;
Schäfer, Jonas (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Blumenberg, Viktoria (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Schmidt, Christian (Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany) ;
Sohlbach, Kristina (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
von Bergwelt-Baildon, Michael (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Bachy, Emmanuel (Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France) ;
Barba, Pere (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Subklewe, Marion (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany)
2022 -  10.1182/bloodadvances.2022007776
Blood advances, Vol. 6 (august 2022) , p. 4719-4725
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
